within Pharmacolibrary.Drugs.ATC.A;

model A10BX18
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.65,
    Cl             = 12.0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 75 / 1000000,
    adminCount     = 1,
    Vd             = 0.08159999999999999,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0125,
    Tlag           = 19.8
  );

  annotation(Documentation(
    info ="<html><body><p>Dorzagliatin is a novel, dual-acting glucokinase activator developed for the treatment of type 2 diabetes mellitus. It acts to enhance glucose homeostasis by improving both pancreatic beta-cell function and hepatic glucose uptake. Dorzagliatin is approved for use in China for patients with type 2 diabetes.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters observed in healthy Chinese adult subjects after single oral administration.</p><h4>References</h4><ol><li><p>Zhu, D, et al., &amp; Chen, L (2018). Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study. <i>The lancet. Diabetes &amp; endocrinology</i> 6(8) 627–636. DOI:<a href=&quot;https://doi.org/10.1016/S2213-8587(18)30105-0&quot;>10.1016/S2213-8587(18)30105-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29735394/&quot;>https://pubmed.ncbi.nlm.nih.gov/29735394</a></p></li><li><p>Chen, L, et al., &amp; Tracey, GJ (2023). A phase I open-label clinical trial to study drug-drug interactions of Dorzagliatin and Sitagliptin in patients with type 2 diabetes and obesity. <i>Nature communications</i> 14(1) 1405–None. DOI:<a href=&quot;https://doi.org/10.1038/s41467-023-36946-7&quot;>10.1038/s41467-023-36946-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36918550/&quot;>https://pubmed.ncbi.nlm.nih.gov/36918550</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A10BX18;
